MedTrace Logo

Macular Hole After Diabetic Vitrectomy

NCT03525899 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2018-05-16

No results posted yet for this study

Summary

To present the clinical characteristics and rational treatment of macular hole (MH) after the diabetic vitrectomy (DV) in patients with proliferative diabetic retinopathy (PDR).

Conditions

  • Proliferative Diabetic Retinopathy
  • Macular Holes

Interventions

PROCEDURE

Pars plana vitrectomy

Pars plana vitrectomy combined with Internal limiting membrane peeling, inverted internal limiting membrane flap insertion into the macular hole, or lens anterior or posterior capsular flap insertion into the macular hole

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Chung-May Yang, MD · National Taiwan University Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2017-12-01
Completion
2017-12-01

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03525899 on ClinicalTrials.gov